Ablative Radiotherapy for Unfavorable Prostate Tumors (ABRUPT): Analysis of Toxicity and Quality of Life from a Prospective Study
0
Authors
Stefano Arcangeli
Stefano Arcangeli•C. Chissotti•D. Panizza
Published
July 1, 2024
Abstract
To assess late gastrointestinal (GI) and genitourinary (GU) side effects in patients with organ-confined unfavorable prostate cancer (PCa) treated with single dose ablative radiotherapy (SDRT).
